Drug Database
Back to search

Netherlands· NL-17486df1f4de

Indigokarmijn Serb 40 mg/5 ml, oplossing voor injectie

A indigo carmine product containing indigokarmijn (e 132), registered in Netherlands by SERB S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC V04CH02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedIndigokarmijn Serb 40 mg/5 ml, oploss…ATCV04CH02REGISTER NO.NL-17486df1f4dePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about indigokarmijn (e 132)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Indigo carmine is registered in 10 of 19 countries.

Countries holding a registration under ATC V04CH02 (indigo carmine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search indigo carmine products by name

Indigo carmine · ATC V04CH02

10 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
INDIGOKARMIJN (E 132)
Manufacturer
SERB S.A.
Country
Netherlands (NL)
ATC code
V04CH02
ATC class
Indigo carmine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    116638

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Indigo carmine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indigo carmine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/899bdddc-ac61-4f6f-aa07-0e658d1c85dd
GET /v1/drugs/899bdddc-ac61-4f6f-aa07-0e658d1c85dd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116638_smpc.pdf",
  "strength": null,
  "atc_label": "Indigo Carmine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116638",
  "excipients": [
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "INDIGOKARMIJN (E 132)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116638.pdf",
  "authorised_at": "2015/10/30",
  "procedure_number": "FR/H/0577/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116638",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about indigo carmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console